Addex Therapeutics Ltd Total Liabilities

Latest as of March 2026: CHF1.47 Million CHF ≈ $1.86 Million USD

Addex Therapeutics Ltd total liabilities. Based on the latest financial reports, Addex Therapeutics Ltd (ADXN) has total liabilities worth CHF1.47 Million CHF (≈ $1.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ADXN asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Addex Therapeutics Ltd (2006–2025)

Total liabilities of Addex Therapeutics Ltd from 2006 to 2025. This chart illustrates how Addex Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Addex Therapeutics Ltd (ADXN) long-term investment share to see how much of total assets are deployed in long-term investments.

Addex Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of Addex Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Octopus Renewables Infra Trust LSE:ORIT	UK	GBX1.50 Million
Classic Minerals Ltd AU:CLZ	Australia	AU$29.77 Million
TZ Ltd AU:TZL	Australia	AU$17.89 Million
Frp Advisory Group Plc LSE:FRP	UK	GBX63.10 Million
Groupe Airwell Société anonyme PA:ALAIR	France	€35.54 Million
Euro Menkul Kiymet Yatirim Ortakligi AS IS:EUYO	Turkey	TL5.13 Million
IQE PLC LSE:IQE	UK	GBX122.20 Million
Aeeris Ltd AU:AER	Australia	AU$798.14K

Liability Composition Analysis (2006–2025)

This chart breaks down Addex Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Addex Therapeutics Ltd.

Liquidity & Leverage Metrics

Addex Therapeutics Ltd Total Liabilities Ratios Explained

Addex Therapeutics Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.97	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.45	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Addex Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Addex Therapeutics Ltd (2006–2025)

The table below shows the annual total liabilities of Addex Therapeutics Ltd from 2006 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF1.60 Million ≈ $2.02 Million	+59.59%
2024-12-31	CHF1.00 Million ≈ $1.27 Million	-71.37%
2023-12-31	CHF3.50 Million ≈ $4.42 Million	+3.78%
2022-12-31	CHF3.37 Million ≈ $4.26 Million	-39.95%
2021-12-31	CHF5.61 Million ≈ $7.09 Million	+0.69%
2020-12-31	CHF5.57 Million ≈ $7.04 Million	-25.76%
2019-12-31	CHF7.50 Million ≈ $9.49 Million	+152.42%
2018-12-31	CHF2.97 Million ≈ $3.76 Million	+72.79%
2017-12-31	CHF1.72 Million ≈ $2.18 Million	+17.50%
2016-12-31	CHF1.46 Million ≈ $1.85 Million	+19.49%
2015-12-31	CHF1.23 Million ≈ $1.55 Million	-25.89%
2014-12-31	CHF1.65 Million ≈ $2.09 Million	-42.06%
2013-12-31	CHF2.85 Million ≈ $3.61 Million	-47.59%
2012-12-31	CHF5.44 Million ≈ $6.88 Million	-44.33%
2011-12-31	CHF9.78 Million ≈ $12.36 Million	-0.91%
2010-12-31	CHF9.87 Million ≈ $12.48 Million	-10.05%
2009-12-31	CHF10.97 Million ≈ $13.87 Million	-17.73%
2008-12-31	CHF13.34 Million ≈ $16.86 Million	+43.92%
2007-12-31	CHF9.27 Million ≈ $11.72 Million	+127.45%
2006-12-31	CHF4.07 Million ≈ $5.15 Million	--

About Addex Therapeutics Ltd

SW:ADXN Switzerland Biotechnology

Market Cap

$4.34 Million

CHF3.43 Million CHF

Market Cap Rank

#29005 Global

#213 in Switzerland

Share Price

CHF0.02

Change (1 day)

+0.00%

52-Week Range

CHF0.02 - CHF0.07

All Time High

CHF3.90